Core Viewpoint - Sotera Health Company has appointed Richard G. Kyle as a new independent director to its Board of Directors, enhancing its leadership team with his extensive experience in operations and governance [1][2][3]. Group 1: Appointment Details - Richard G. Kyle will serve on the Leadership Development and Compensation Committee and the Nominating and Corporate Governance Committee [1]. - His previous role was as President and CEO of The Timken Company, where he led financial transformation and strategic diversification [2]. - Kyle's selection is based on his experience in leading global operations and strong financial acumen [2][3]. Group 2: Leadership Insights - Michael B. Petras, Jr., Chairman and CEO of Sotera Health, expressed excitement about Kyle's appointment, highlighting his leadership experience as a public company CEO [3]. - Kyle continues to serve on Timken's Board and has been on the Board of Sonoco Products Company since 2015, where he holds multiple committee roles [3]. Group 3: Company Overview - Sotera Health is a global provider of sterilization solutions, lab testing, and advisory services for the healthcare industry [4]. - The company operates through three business segments: Sterigenics, Nordion, and Nelson Labs, with a commitment to safeguarding global health [4].

Core Viewpoint - Sotera Health Company will present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, highlighting its role as a leading provider of sterilization solutions and lab testing services for the healthcare industry [1]. Group 1 - Sotera Health is recognized as a global leader in providing mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare sector [3]. - The company operates through three main business units: Sterigenics®, Nordion®, and Nelson Labs® [3]. - The company is dedicated to its mission of "Safeguarding Global Health®" [3]. Group 2 - A live webcast of the presentation will be accessible on the Investor Relations section of the company's website, with a replay available within 48 hours [2]. - Updates relevant to investors can be found in the Investor Relations section of the company's website [4].

Core Viewpoint - Sotera Health Company will release its financial results for the second quarter ended June 30, 2025, on August 8, 2025, before market opening, followed by a conference call to discuss the results and operating highlights [1]. Company Overview - Sotera Health is a leading global provider of end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, operating through three businesses: Sterigenics, Nordion, and Nelson Labs [3]. - The company's mission is to safeguard global health [3]. Conference Call Details - The conference call will take place at 9:00 a.m. Eastern Daylight Time on August 8, 2025, with participation options provided for both U.S. and international callers [2]. - A live webcast of the conference call will be available on the company's website, along with accompanying materials, and a replay will be accessible later that day [2].